AMRN(AMRN)
AMRN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $177M | $177M | $172M | $234M |
| Low | $173M | $172M | $158M | $228M |
| High | $182M | $181M | $185M | $240M |
| EBITDA Avg | $-32M | $-32M | $-31M | $-42M |
| Low | $-33M | $-32M | $-33M | $-43M |
| High | $-31M | $-31M | $-28M | $-41M |
| EBIT Avg | $-33M | $-33M | $-32M | $-44M |
| Low | $-34M | $-34M | $-35M | $-45M |
| High | $-33M | $-32M | $-30M | $-43M |
| Net Income Avg | $-12M | $-7M | $-9M | $4M |
| Low | $-13M | $-7M | $-10M | $4M |
| High | $-12M | $-7M | $-9M | $4M |
| EPS Avg | $-0.60 | $-0.34 | $-0.44 | $0.19 |
| Low | $-0.62 | $-0.36 | $-0.46 | $0.18 |
| High | $-0.58 | $-0.33 | $-0.43 | $0.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $44M | $47M | $42M | $40M |
| Low | $44M | $47M | $42M | $40M |
| High | $44M | $47M | $42M | $40M |
| EBITDA Avg | $-8M | $-8M | $-7M | $-7M |
| Low | $-8M | $-8M | $-7M | $-7M |
| High | $-8M | $-8M | $-7M | $-7M |
| EBIT Avg | $-8M | $-9M | $-8M | $-8M |
| Low | $-8M | $-9M | $-8M | $-8M |
| High | $-8M | $-9M | $-8M | $-8M |
| Net Income Avg | $-2M | $-983,078 | $-208,222 | $-416,444 |
| Low | $-2M | $-983,078 | $-208,222 | $-416,444 |
| High | $-2M | $-983,078 | $-208,222 | $-416,444 |
| EPS Avg | $-0.10 | $-0.05 | $-0.01 | $-0.02 |
| Low | $-0.10 | $-0.05 | $-0.01 | $-0.02 |
| High | $-0.10 | $-0.05 | $-0.01 | $-0.02 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |